OncoResponse: OncoResponse reports data from Phase I solid tumour treatment trial
OncoResponse has unveiled the outcomes from the Phase I trial of OR502 for treating advanced solid tumours. The post OncoResponse reports data from Phase I solid tumour treatment trial appeared first on Clinical Trials Arena.
Read full article »
OncoResponse is a Washington-based biotechnology company that researches and develops immunotherapies for the treatment of cancer.
Read more